News
-
Scalp itch relief in minutes with Dermal Therapy
Wednesday | Apr 9 2025DERMAL Therapy Scalp Relief Shampoo & Conditioner is a two-in-one steroid and tar-free formula designed specifically for dry, itchy or sensitive scalp.
-
Revive Tears – PBS-listed
Wednesday | Apr 9 2025REVIVE Tears lubricant eye drops provide long lasting and soothing relief against burning, irritation and discomfort due to dry eye.
-
APC welcomes new leadership
Tuesday | Apr 8 2025THE Australian Pharmacy Council (APC) has welcomed the appointment of Professor Rhonda Clifford as the incoming Chair of the APC Accreditation Committee.
-
World Health Day family focus
Tuesday | Apr 8 2025WORLD Health Day yesterday kicked off a year-long campaign on maternal and child health, with the Pharmacy Guild of Australia recognising the role of community pharmacists in supporting families to get the healthcare they need.
-
Isotretinoin PI/CMI warnings upgraded
Tuesday | Apr 8 2025THE Therapeutic Goods Administration (TGA) has advised that the product information (PI) and consumer medicine information (CMI) leaflets for acne medication isotretinoin (Roaccutane and generics) contain updated safety information with regards to mental health and sexual disorders.
-
PSA leading in QUM and meds safety
Tuesday | Apr 8 2025THE Pharmaceutical Society of Australia (PSA) has secured involvement in six key health professional projects and one consumer-focused initiative under the Australian Government's recently announced Quality Use of Diagnostics, Therapeutics and Pathology (QUDPT) grants.
-
Guild Victoria calls for free flu shots
Tuesday | Apr 8 2025WITH around double the number of flu cases already recorded in Victoria compared to the same time last year, the Pharmacy Guild of Australia, Victoria Branch, is urging the State Government to fund a free flu vaccination program in community pharmacies for this and future flu seasons.
-
Diabetes meds reduce dementia
Tuesday | Apr 8 2025TWO new studies published today in JAMA Neurology have confirmed previous observations that glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) reduce the risk of Alzheimer's and related dementias in people with type 2 diabetes.
-
Dispensary Corner 08 Apr 25
Tuesday | Apr 8 2025JAPANESE scientists have come to the alarming conclusion that a lack of sex or sexual interest has a direct correlation in a higher risk of death, cancer and other long-term illnesses.
-
Rethinking health literacy in T2D
Monday | Apr 7 2025NEW research has found limited evidence for an association between health literacy and medication adherence among ethnic minority adults living with type 2 diabetes (T2D).
